Details for 2023160111

Up to date per 04.04.2026

Actions

Title / Product Name

HEMMUNG VON HSD17B13 IN DER BEHANDLUNG DER LEBERERKRANKUNG BEI PATIENTEN, DIE DIE PNPLA3-I148M-VARIATION EXPRIMIEREN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2023160111

EP Publication Number

4234719

E-Number

1861123

Language

PCT Number

Publication Date

30.08.2023 A

26.11.2025 B1

Registration Date

26.11.2025

AT Publication Date

15.12.2025

Application Date

11.10.2018

Registration Number

Priorities

11.10.2017

201762570985 P

IPC

C12Q 1/6883 20180101AFI20230911BHEP

Maximum Duration of Protection

11.10.2038

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591US

Representative

No representatives present

Inventor

XIN, Yurong Tarrytown, 10591US

GROMADA, Jesper Tarrytown, 10591US

CHENG, Xiping Tarrytown, 10591US

DEWEY, Frederick Tarrytown, 10591US

TESLOVICH DOSTAL, Tanya Tarrytown, 10591US

SCHURMANN, Claudia Tarrytown, 10591US

BARAS, Aris Bedford Corners, 10549US

ABUL-HUSN, Noura New York, 10128US